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Abstract
Protein tyrosine nitration is an important molecular event in nervous system tumor such 
as glioma and pituitary adenomas. It is the essential step to identify the protein targets 
and exact modified sites of tyrosine nitration for addressing the biological roles of pro-
tein tyrosine nitration in nervous system tumors and discovering effective biomarkers to 
understand in-depth molecular mechanisms and determine new diagnosis strategy and 
novel therapeutic targets. One/two-dimensional gel electrophoresis (1DGE, 2DGE), or 
nitrotyrosine affinity column (NTAC), coupled with tandem mass spectrometry (MS/MS) 
have been successfully applied in the analysis of nitroproteins in nervous system tumors. 
This article address the basic concept of protein tyrosine nitration, nitroproteomics meth-
odology based on gel electrophoresis/immunoaffinity enrichment and tandem mass 
spectrometry, and the current status of nitroprotein study in nervous system tumors. 
The established nitroproteomics approach is easily translated to study other diseases.
Keywords: two-dimensional gel electrophoresis, one-dimensional gel electrophoresis, 
tandem mass spectrometry, tyrosine nitration, nitroprotein, nitroproteomics, nervous 
system tumors
1. Introduction
The incidence of central nervous system (CNS) has been increasing over the last 30 years, and 
unfortunately, become younger and younger [1]. More remarkable, patients (20–40%) with 
systemic cancer will occur metastatic disease to the CNS [2]. Primary malignant brain tumors 
and other metastatic disease to the CNS threaten human health. Astrocytoma is a type of pri-
mary malignant brain tumor that range from 20 to 40% of glioma, which is the most  common 
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primary brain tumor in adults [3]. Here, we put research emphasis on two kinds of primary 
intracranial tumor, astrocytomas and pituitary adenomas. Astrocytomas cells possess the 
characteristic of high invasion to cause difficulty in therapy and high mortality (median sur-
vival = 9–12 months) [4]. A pituitary adenoma is quite common, and accounts for 10% of all 
primary intracranial neoplasias [5]. Even only a minority of pituitary adenomas (0.1–0.2%) 
develops into metastatic cancer, pituitary adenomas arise clinical problems: (a) Compress 
the adjacent brain organs appear symptoms including headache and visual failure. (b) An 
inappropriate hormone secretion led to hormone syndromes, including hypopituitarism, 
acromegaly, hyperprolactinemia and Cushing’s syndrome [6]. The molecular mechanisms of 
those diseases remain unclear, and the traditional treatment models contain surgical excision, 
radiotherapy, and medical therapies [7]. Discovering in-depth molecular mechanisms, new 
diagnosis strategy, novel therapeutic targets are urgent.
Protein tyrosine nitration is an important posttranslational modification (PTM) in nervous 
system tumors that is related with multiple abnormal pathophysiological processes [8]. The 
process of protein tyrosine nitration is formed from 3-nitrotyrosine group to position 3 of 
the tyrosine residue phenolic ring [9], which alters the electron density and pKa value (from 
~10 for tyrosine into ~7.1 for 3-nitrotyrosine) of the tyrosine phenolic ring [10]. Such changes 
affect biochemical characteristics of the tyrosine residue that will change interaction between 
enzyme-substrate, antigen–antibody or receptor-ligand, when interacting regions were in 
nitration. Reactive nitrogen species (RNS) act as an important mediated material for protein 
nitration, and our studies [11] consistent with others [12, 13] have indicated that nitric oxide 
and protein nitration may play important roles in the nervous system tumors. Previous stud-
ies reported that (1) the inflammatory reaction is involved in nervous system tumors [14]; (2) 
NO and RNS are important inflammatory mediators [15]; and (3) increased production of 
NO, peroxinitrite and superoxide, occurs in nervous system tumors [16]; (4) higher levels of 
nitrotyrosine are observed in nervous system tumors than normal tissues with biochemical 
approaches and immunohistochemical, and only protein nitrotubulin and protein nitro-p53 
have been determined in human nervous system tumors [17]. Furthermore, the amino acid 
analog 3-nitrotyrosine due to functional and morphological injury of mouse-neuroblastoma 
cell lines and rat-glioma cell lines [18]. These studies demonstrated the importance of protein 
tyrosine nitration in the pathogenesis of nervous system tumors. Illustrating the functions of 
nitroproteins might reveal in-depth molecular mechanisms and biological function of tyro-
sine nitration in human nervous system tumors. Literature-based review and comprehen-
sive annotation of proteins on the SwissProt website were used to expound the nitroprotein 
domains/motifs, location of nitrotyrosine sites and possible signaling pathways relevant to 
nervous system tumors. Nitroproteins took part in multiple biological processes in the devel-
opment of tumors as follows: (a) tumor cell migration and invasion [19]; (b) cell proliferation 
and apoptosis [20]; (c) chemotherapy resistance [21]; (d) signal transduction [22]; (e) pheno-
typic dedifferentiation [23]; (f) microtubule dynamic stabilization [24]; (g) tumor recurrence; 
(h) others such as immunoreaction and post-transcriptional regulation. Moreover, the discov-
ery of tyrosine nitration being a reversible reaction [25] and having a competition between 
phosphorylation motif [26], led us to speculate that dynamic process of protein nitration 
might also be regulated and controlled. However, no definite target of intervention is found 
for tyrosine nitration in human nervous system tumors. It takes long time to study tumor-
related nitroproteins and to illustrate molecular mechanisms in tumor formation.
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Nitroproteomics methods were based on sample enrichment and mass spectrometry analy-
sis. Modern nitroproteomics applies protein-separation-enrichment techniques such as gel 
methods and non-gel methods, including immunoprecipitation [11], anti-nitrotyrosine anti-
body-based enzyme-linked immunosorbent assay (ELISA) [27], and one/two-dimensional gel 
electrophoresis (1DGE/2DGE)-based Western blot analyses [9]. 1DGE/2DGE-based Western 
blots analyses can separate and preferentially enrich endogenous nitroproteins and also pre-
liminarily determine the quantitative information of nitrotyrosine. Studies showed that the 
same protein was detected at multiple gel-spots on 2D electrophoresis gels, and single 2D elec-
trophoresis gel-spot usually contains several proteins [28]. Therefore, 2D electrophoresis gel 
has advantages in protein component visualization, detection of protein species that are mainly 
derived from alternative splicing or PTMs [9]. Protein isoforms or variants present dynamic 
biological processes in vivo, and different protein species associated with different conditions 
and pathophysiological status [29]. We adopted 1DGE/2DGE-based Western blots analyses 
method: the scanned images of the silver-stained 2D electrophoresis gels and the visualization 
of Western blot membranes were input to a PDQuest system (Bio-Rad, version 7.1, Hercules, 
CA) to composite image that contained the Gaussian spots [30]. MS/MS is the mainstream tech-
nique to identify protein species and PTMs products with verification of amino acid sequence, 
splicing sites, and modification site [31]. However, it is also pointed out that the challenges 
faced by low abundance of tyrosine nitration and the elusive mass spectrometry result of a 
nitro group are existed [32]. For example, matrix-assisted laser desorption ionization (MALDI) 
is quite different from electrospray ionization (ESI)-MS when study the MS behaviors of a nitro-
peptide [33]. Photochemical decompositions of the nitro group (–NO
2
) induced by the high-
energy laser decrease the precursor-ion intensity of a nitropeptide, making an MS spectrum 
much more complex in process of MALDI. However, the decomposition pattern of a nitropep-
tide was well clarified by the photochemical decomposition pattern ([M + H]+, [M + H – 16]+, 
[M + H –30]+, and [M + H – 32]+). Even ESI does not produce photochemical decompositions, 
scanning for the characteristic immonium ion (m/z 181.06) by the precursor ion could help 
accurately identify a nitropeptide or nitroprotein under ESI conditions [34]. Above key factors, 
including low abundance of nitroproteins, preferential enrichment methods, sensitivity of MS 
analysis, complicated MS behaviors of a nitro group, that all determine success or failure in 
the identity of in vivo nitroproteins. Thus, nitropeptide was detected by a vMALDI MS/MS 
method [9, 11]. Accumulation of MS/MS scans was used to increase the signal-to-noise ratio 
(S/N), which is needed for the detection of endogenous nitroproteins. A single MS/MS scan can 
determine an amino acid sequence to study proteome and phosphoproteome.
Protein tyrosine nitration is an (PTM) in nervous system tumor such as astrocytoma and 
pituitary adenomas, and participates in multiple complex biological processes [9, 11, 35, 36]. 
For human astrocytoma and pituitary adenomas nitroproteomics studies, 2DGE-based nitro-
tyrosine Western blot analysis with MALDI-TOF were used to identify endogenous nitro-
proteins and nitrotyrosine sites from human pituitary control and adenoma tissues, and 
2DGE-based nitro-tyrosine Western blot analysis with liquid chromatography-electrospray 
 ionization-quadrupole ion trap (LC-ESI-Q-IT) were used to identify endogenous nitroproteins 
and nitrotyrosine sites from human astrocytoma brain tissues. Bioinformatics and pathway 
analysis were used to determine domains/motifs in a nitroprotein, location of nitrotyrosine 
sites, and possible signaling pathways. A total of eight nitrotyrosine-containing proteins in 
human pituitary control tissues [9, 36], and nine nitroproteins and three nitroprotein-interacting 
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proteins in a human nonfunctional pituitary adenoma tissue [11], 18 nitroproteins and their 23 
nitrotyrosine sites in human astrocytoma tissues [35], were identified with 2DE-MS/MS. The 
nitration site was located onto the corresponding functional domain, and each nitroprotein 
was carried out pathway analysis to speculate the possible biological function.
2. Materials and methods
2.1. Tissues and extraction of proteins
A clinically nonfunctional human pituitary adenoma tissue was obtained during surgery. The 
expression of FSH, LH, GH, prolactin, TSH, and ACTH were all negative in tumor cells [11]. 
A normal human pituitary tissue acted as control group was obtained from the post-mor-
tem sample (a drowning male) [9, 36]. Human astrocytoma brain tissues (including different 
clinical staging-I/II/III/IV) were obtained from the Department of Neurosurgery of Xiangya 
Hospital, China [35]. The tissues were frozen in liquid nitrogen immediately, then stored at 
−80°C. According to the protein extraction manuals (Pierce, Rockford, IL, USA),supernatant 
of the tissue lysate was extracted for further analysis.
2.2. 2DGE-based western blot detection of nitroproteins
2DGE: The precast IPG strips (pH 3–10 NL; 180 × 3 × 0.5 mm) and 18-cm IPGstrip holder 
was used for 2DGE first dimension—isoelectic focusing (IEF) on an IPGphor instrument (GE 
Heathcare) to separate protein sample. After IEF, the IPG strip was processed for 2DGE sec-
ond dimension—sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), 
namely, the equilibrated proteins in the IPG strips were separated by molecular weight dur-
ing electrophoresis on in 12% PAGE resolving gel (250 × 215 × 1.0 mm), and visualized with 
silver-staining [9, 36] or Coomassie brilliant blue G staining [35].
2DGE-based Western blotting: The 2DGE-separated proteins were transferred to a PVDF 
membrane, which were blocked by BSA, incubated with an anti-human nitrotyrosine anti-
body and secondary antibody, then visualized with 1-Step™ nitro blue tetrazolium/5-bromo-
4-chloro-3-indolyl phosphate (NBT/BCIP) (Thermo Product No. 3404).
Image analysis of a 2D gel and of 2D-Western blotting: The scanned images of the 2D gels 
and the Western blot membranes were input to a PDQuest analysis system (Bio-Rad, version 
7.1, Hercules, CA) to synthesize image. Gaussian spots were applied to all subsequent spot-
matching and analyses. Each spot volume was normalized to the total optical density (OD) to 
minimize experimental factors on a spot volume [30].
2.3. MS/MS characterization of tryptic nitropeptides from nitroproteins
LC-ESI-MS/MS: The nitrotyrosine-positive gel-spots were excised, digested, purified, eluted, 
air-dried, redissolved. Then, the peptide mixture was subjected to LC-ESI-quadrupole-time of 
flight (LC-ESI-qTOF) or LTQ-OrbiTrap Velos MS/MS analyses. The detailed operation process 
and parameter settings have been described [35].
Electrophoresis - Life Sciences Practical Applications110
MALDI-MS/MS: The immunopositive 2D gel spots were excised, digested, purified, eluted, air-
dried, redissolved, and were spots onto MALDI-plate, which were subjected to MALDI-MS/
MS analysis [37]. The detailed procedure has been described [9, 11, 36].
2.4. Identification of nitroproteins with MS/MS
MS/MS data were used to identify the protein and nitrotyrosine sites by searching the 
SwissProt and NCBInr databases with SQUEST or Mascot software, with mass modifica-
tions of +45 Da (+NO
2
 – H) at Tyr, +57 Da (+NH
2
COCH
2
 – H) at Cys, +16 Da (oxidation) at 
Met. Protein domains and motifs analyses were carried out with ScanProsite software (http://
us.expasy.org/tools/scanprosite). Nitrotyrosine sites within a given domain or motif were 
determined with MotifScan software (http://myhits.isb-sib.ch/cgi-bin/motif_scan). The func-
tions and experimental data-based model of nitroproteins was searched on the Swiss-Prot 
database annotation page and the related literature resources.
2.5. Annotation of functional characteristics of the nitroproteins
Literature-based bioinformatics and comprehensive annotation of protein in the SwissProt 
page were used to rationalize the functional characteristics of each nitroprotein, and to pro-
vide important clues to the biological significance of each nitroprotein relevant to tumors.
3. Results and discussions
3.1. The level of protein tyrosine nitration in nervous system tumors
One1D gel-based Western blotting in combination with anti-nitrotyrosine antibody analysis 
revealed that the overall level of protein tyrosine nitration in astrocytoma was significantly 
higher than the controls (Figure 1).
3.2. Enrichment of endogenous nitroproteins in nervous system tumors
The challenges faced by low abundance of tyrosine nitration and the elusive mass spectrometry 
result of a nitro group are existed. Modern nitroproteomics applies protein-separation-enrichment 
techniques such as gel methods and non-gel methods, including immunoprecipitation [11, 37], 
anti-nitrotyrosine antibody-based enzyme-linked immunosorbent assay (ELISA) [27], and 
one/two-dimensional gel electrophoresis (1DGE/2DGE)-based Western blot analyses [9, 35]. 
1DGE/2DGE-based Western blots analyses can separate and preferentially enrich endogenous 
nitroproteins and also preliminarily determine the quantitative information of nitrotyrosine. 
It should not be neglected that limitations of 2DGE-based method including coverage of 
proteome, dynamic range, sensitivity and throughput, which always were restricted by the 
amount of samples. Also, the non-nitrated tryptic peptides are much more than nitrated tryp-
tic peptides after a 2DGE-separated nitroprotein was digested, which will interrupt MS/MS 
signal of nitrated tryptic peptides [38]. However, for the proteome study, a 2DGE gel could 
detect more than 1000 spots [39]. Different proteins may be contained within the same spot [40]. 
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Many proteins were detected in several analyzed spots showing 2DE-MS separate ability at 
the protein species level [43]. Indeed, higher sensitivity had been expected when 2DE coupled 
with high-sensitivity LC–MS, and will detect, identify and quantify human proteome nearly 
500,000 (with an estimated resolution) protein species [28]. We adopted 2DGE-based Western 
blots analyses method to separate and detect nitroproteins in nervous system tumors. Our 
previous study obtained enrichment of endogenous nitroproteins in human pituitary [9, 36] 
and astrocytoma [35].
The 2DGE-based Western blot coupled with anti-nitrotyrosine antibody was used to ana-
lyze nitroproteins in human astrocytoma tissues (Figure 2) [17]. Nearly 1100 protein spots 
were detected in each Coomassie-stained 2D gel. Most proteins were distributed within a 
range of pI 4–8 and Mr. of 15–150 kDa. A total of 57 nitrotyrosine-immunopositive gel spots 
were detected, and each positive spot corresponded to a Coomassie-stained 2D gel spot. In 
order to show non-specific nitrotyrosine-immunopositive Western blot spots, we setup a 
control experiment without primary antibody to determine cross-reactivity of the secondary 
antibody.
Figure 1. The nitrotyrosine immunoactivities in different grade (I, II, III, and IV) of astrocytoma tissues relative to normal 
controls (N), detected with nitrotyrosine immunoaffinty-based western blotting (n = 3). Tumor = sum of different grade 
(I, II, III, and IV) of astrocytomas. *p < 0.05. Reproduced from Peng and Zhan [35], with permission from Springer, 
copyright 2015.
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A similar 2DGE-based Western blot coupled with anti-nitrotyrosine antibody was used to 
analyze nitroproteins in human pituitary tissues [35, 38]. Each pituitary silver-stained 2D gel 
image (pI 3–10; Mr. 10–100 kDa) contained ca. 1000 protein spots, and a total of 32 nitrotyro-
sine immunopositive Western blot spots were detected in human pituitary tissues.
An immunoprecipitation, nitrotyrosine affinity column (NTAC)-based MS/MS approach was 
also used to enrich and identify nitroproteins from a pituitary adenoma tissue (Figure 3) [37]. 
Briefly, the NTAC was prepared with protein G beads cross-linked with anti-nitrotyrosine 
antibodies. A volume (600 μl) of protein extracts from 62 mg wet weight of a pituitary  adenoma 
Figure 2. 2DGE-based Western blot analysis of nitroproteins in an IV-grade astrocytoma tissue (500 μg protein per 2D 
gel). (A) Coomassie blue-stained 2DGE image (before transfer of proteins). (B) Coomassie blue-stained 2DGE image 
(after transfer of proteins). (C) Western blotting image of nitroproteins (anti-nitrotyrosine antibodies + secondary 
antibodies). (D) Negative control of Western blotting to show the cross-reaction of the secondary antibody (only the 
secondary antibody; no anti-nitrotyrosine antibody). Reproduced from Peng and Zhan [35], with permission from 
Springer, copyright 2015.
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tissue was diluted (1,1, v/v) with binding/washing buffer. Then, 500 μl diluted sample was 
incubated with the prepared NTAC to enrich and isolate nitroproteins and nitroprotein–pro-
tein complexes, followed by tripsin digestion and MS/MS identification.
3.3. MS/MS identification of nitroproteins and nitrated sites in nervous system 
tumors
MS/MS is the mainstream technique to identify protein species and PTMs products with veri-
fication of amino acid sequence, splicing sites, and modification site [31]. However, the very 
low abundance of tyrosine nitration in a proteome (one nitration in ~106 tyrosine residues) 
and the complicated mass spectrometry behaviors of a nitro group that we studied in nitro-
proteins complicate analyses [34, 38]. Different mass spectrometry has different advantages 
and complicated mass spectrometry behaviors, so choosing the proper method or combina-
tion with each other is necessary. For example, the MS behaviors of a nitropeptide differ 
significantly between matrix-assisted laser desorption ionization (MALDI)-and electrospray 
ionization (ESI)-MS on process of photochemical decompositions of the nitro group (–NO
2
) 
Figure 3. The use of NTAC to characterize nitroproteins and their complexes. A parallel control experiment was carried 
out without any anti-3-nitrotyrosine antibody. Reproduced from Zhan and Desiderio [11], with permission from Elsevier 
Science, copyright 2006.
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[33, 41]. Additionally, Specificity and sensitivity of the MALDI–LTQ MS/MS analytical system 
to characterize each nitroprotein and nitroprotein–protein complex should be considered. 
According to our previous experience [42], MALDI–LTQ has a number of advantages: (1) 
highly sensitive; (2) high accuracy measurement on amino acid sequence and nitration sites; 
(3) a prepared sample could be reanalyzed in several weeks.
For human astrocytoma and pituitary adenomas nitroproteomics studies, 2DGE-based nitroty-
rosine Western blot analysis with MALDI-TOF were used to obtain endogenous nitroproteins 
from human pituitary control and adenoma tissues, and 2DGE-based nitrotyrosine Western blot 
analysis with liquid chromatography-electrospray ionization-quadrupole ion trap (LC-ESI-Q-IT) 
were used to obtain endogenous nitroproteins from human astrocytoma brain tissues, flowed 
by identification of nitroproteins, proteins interacted with nitroproteins and nitrotyrosine sites. 
A representative MS/MS spectrum was shown to identify nitropeptide (ITFDDnYIAC*C*VK) 
that is derived from sorcin (C9J0K6) in human astrocytoma tissue (Figure 4).
A total of eight nitroproteins was identified in human normal pituitary tissues with 2DGE-MS/
MS [9, 36], and nine nitroproteins were identified in a human nonfunctional pituitary adenoma 
tissue with NTAC-MS/MS [11], and 18 nitroproteins and their 20 nitrotyrosine sites was identi-
fied in a human astrocytoma tissue with 2DGE-MS/MS [35] (Table 1). Three  nitroprotein–protein 
complexes were also identified in a human nonfunctional pituitary adenoma tissue: the 
nitrated beta-subunit of cAMP-dependent protein kinase (PKA) complex, the nitrated pro-
teasome–ubiquitin complex, and the nitrated interleukin 1 family member 6–interleukin 1 
receptor–interleukin 1 receptor-associated kinase-like 2 (IL1-F6–IL1-R–IRAK-2) complex [37].
Furthermore, the 2DE-MS/MS-identified nitrosorcin in astrocytoma tissues was confirmed 
with immunoprecipitation coupled with 1D gel-Western blot experiments (Figure 5). The 
tyrosine nitration of sorcin was measured by immunoprecipitation coupled with Western 
blotting between IV-grade astrocytoma and normal control (N) tissues. Thus overall status of 
tyrosine nitration in the whole tissues could be displayed with anti-nitrotyrosine antibody. 
The results confirmed the tyrosine nitration of sorcin in astrocytoma, and the level of tyrosine 
nitration of sorcin in astrocytoma is obviously higher than the control tissues.
3.4. Functional characteristics of the nitroproteins
Comprehensive analysis of the functional characteristics of those nine nitroproteins and three 
nitroproten-protein complexes in a pituitary adenoma biological system revealed several 
important functional pathways involved in protein tyrosine nitration (Figure 6): Nitrated 
RHOGAP5 and nitrated rhophilin 2 are involved in the GTPase signal pathway. Nitrated 
CENT-beta 1 and nitrated PKAR1-beta are involved in the PKA signal pathway. IRAK-2 in 
the IL1-R complex and nitrated IL1-F6 are involved in the cytokine system. The nitrated pro-
teasome–ubiquitin complex is an important enzymatic complex involved in the intracellular 
nonlysosomal proteolytic pathway. Nitrated LIRA4 might be involved in the immune system. 
Nitrated ZFP432 is involved in transcription regulatory systems. The nitrated S1P lyase 1 
participates in sphingolipid metabolism to regulate cell proliferation, survival, and cell death 
as well as the immune system.
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Comprehensive analysis of the functional characteristics of 18 astrocytoma nitropro-
teins revealed those nitroproteins participated in multiple cancer-related biological pro-
cesses (Figure 7): (a) microtubule dynamic stabilization and cytoprotection, which mainly 
involvedβVIII-tubulin, and β-tubulin; (b) tumor migration and metastasis, which mainly 
Nervous system tumors/
control
Nitrated protein name nY site
Pituitary adenoma Rho-GTPase-activating 5 [Q13017] (ARHGAP5) nY550
Leukocyte immunoglobulin-like receptor A4 [P59901] nY404
Zinc finger protein 432 [O94892] nY41
PKA beta regulatory subunit [P31321] (PRKAR1B) nY20
Sphingosine-1-phosphate lyase 1 [O95470] nY356, Y366
Centaurin beta 1 [Q15027] nY485
Proteasome subunit alpha type 2 [P25787] (PSMA2) nY228
Interleukin 1 family member 6 [Q9UHA7] (IL1F6) nY96
Rhophilin 2 [Q8IUC4] (RHPN2) nY258
Figure 4. MS/MS spectrum of a nitropeptide (ITFDDnYIAC*C*VK) that is derived from sorcin (C9J0K6) in astrocytoma 
tissue. nY = nitrotyrosine residue. Reproduced from Peng and Zhan [35], with permission from Springer, copyright 2015.
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involved sorcin, isoform 2 of Toll-like receptor 9, isoform 2 of Arf-GAP with SH3 domain/
ANK repeat and PH domain-containing protein 3, transducin-like enhancer protein 2, and 
GPR52; (c) chemotherapy resistance, which mainly involved Ras-related protein Rab 8, 
Nervous system tumors/
control
Nitrated protein name nY site
Pituitary control Proteasome subunit alpha type 2 (PSMA2) nY228
Mitochondrial co-chaperone protein HscB [Q8IWL3] nY128
Actin [P03996] (ACTA2, ACTG2, ACTC1) nY296
Synaptosomal-associated protein (SNAP91) nY237
Ig alpha Fc receptor [P24071] (FCAR) nY223
Progestin and adipoQ receptor family member III [Q6TCH7] 
(PAQR3)
nY33
PKG 2 [Q13237] (PRKG2) nY354
Stanniocalcin 1[P52823] (STC1) nY159
Astrocytoma Ras-related protein Rab-8B (H0YMN7) nY77;nY78
Isoform 2 of Signal-induced proliferation-associated 1-like protein 
2 (Q9P2F8–2)
nY1369, nY1387
Regulating synaptic membrane exocytosis protein 1 (Q86UR5) nY926
Isoform 2 of Grainyhead-like protein 1 homolog (Q9NZI5–2) nY400, nY402
Probable G-protein coupled receptor 52 (Q9Y2T5) nY281, nY284
Sorcin (C9J0K6) nY116
Tubulin beta chain (P07437) nY106
Tubulin beta-2A chain (Q13885) nY106, nY183, nY200
Tubulin beta-2B chain (Q9BVA1) nY106
Tubulin beta-3 chain (Q13509) nY106
Ig kappa chain V-I region WAT (P80362) nY49
Coiled-coil domain-containing protein 105 (Q8IYK2) nY372
Helicase ARIP4 (E7EU19) nY407
General transcription factor 3C polypeptide 3 (Fragment) 
(H7C0C0)
nY110
Isoform 2 of Arf-GAP with SH3 domain, ANK repeat and PH 
domain-containing protein 2 (O43150–2)
nY75
Isoform 2 of Toll-like receptor 9 (Q9NR96–2) nY419
Transducin-like enhancer protein 2 (B4DE62) nY369
Note: nY = nitrotyrosine. Pituitary adenoma and control modified from Zhan and Desiderio [9, 11, 36], with permission 
from Elsevier Science, copyright 2004, 2006 and 2007. Astrocytoma modified from Peng and Zhan [35], with permission 
from Springer, copyright 2015.
Table 1. Nitroproteins and non-nitrated proteins identified from nervous system tumor.
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Figure 5. Nitrotyrosine immune activities in nitrosorcin-immunoprecipitated products from IV-astrocytoma and normal 
control (N) tissues. Reproduced from Peng and Zhan [35], with permission from springer, copyright 2015.
Figure 6. Experimental data-based model of nitroproteins and their functions in human nonfunctional pituitary adenomas. 
NO
2
−, nitroprotein. Reproduced from Zhan and Desiderio [11], with permission from Elsevier Science, copyright 2006.
Electrophoresis - Life Sciences Practical Applications118
 βIII-tubulin, βIVa-tubulin, βVI-tubulin, and sorcin; (d) cell proliferation and apoptosis, which 
mainly involved а-tubulin, isoform 2 of Grainyhead-like protein 1, Ras-related protein Rab 8, 
regulating synaptic membrane exocytosis protein 1, and coiled-coil domain-containing pro-
tein 105; (e) phenotypic dedifferentiation, which involved gamma-tubulin; (f) signal trans-
duction, which mainly involved isoform 2 of signal-induced proliferation-associated 1-like 
protein 2; (g) others such as transcription, immune response, and transformation; (h) tumor 
malignancy and recurrence-free survival, which involvedβII-tubulin and βIII-tubulin.
4. Conclusion(s)
Protein tyrosine nitration, as one of an important PTMs generated in nervous system tumor, 
participates in multiple complex biological processes, including cell proliferation and apop-
tosis, metastasis, migration, drug-resistance, cytoskeleton, signal transduction, immune 
response and cellular differentiation [43]. What is the mechanism for protein tyrosine nitra-
tion in carcinogenesis and development of malignant tumors? How to identify the protein 
targets and exact modified sites of tyrosine nitration? One/two-dimensional gel electrophore-
sis-based nitrotyrosine Western blot analysis and tandem mass spectrometry have been suc-
cessfully applied in the analysis of nitroproteins in nervous system tumors.
Further study is needed to solve those limits on protein nitration: (1) Protein tyrosine nitration 
and heterogeneity of neoplasm. (2) Three-dimensional spatial structure of a nervous system 
tumor-related nitroprotein. (3) Consistency issues between body fluid and tissue. With the 
clarification of those issues on nitroproteins, protein tyrosine nitration will have a significant 
impact on the field of nervous system tumors.
Figure 7. Experimental data-based diagram that rationalizes nitrotyrosine-containing proteins in the glioma biological 
system. Reproduced from Peng and Zhan [35], with permission from Springer, copyright 2015.
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